In-house counsel

FDA targets faster generic approvals in drive to slash drug prices

FDA targets faster generic approvals in drive to slash drug prices

27 August 2026 Dozens of new and revised guidances could make it faster and less costly to bring generics to market, as the US ramps up pressure on drug prices.

China-origin biotech assets and the hidden question of IP ownership

27 August 2026

The buyers' wishlist: What makes a life sciences deal stack up?

25 August 2026